The antitumor capacity of mesothelin-CAR-T cells in targeting solid tumors in mice

Since the approval of chimeric antigen receptor (CAR) T cell therapy targeting CD19 by the FDA, CAR-T cell therapy has received increasing attention as a new method for targeting tumors. Although CAR-T cell therapy has a good effect against hematological malignancies, it has been less effective agai...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Ther Oncolytics
Main Authors: Zhang, Qian, Liu, Guoping, Liu, Jibin, Yang, Mu, Fu, Juan, Liu, Guodi, Li, Dehua, Gu, Zhangjie, Zhang, Linsong, Pan, Yingjiao, Cui, Xingbing, Wang, Lu, Zhang, Lixin, Tian, Xiaoli
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Gene & Cell Therapy 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7943972/
https://ncbi.nlm.nih.gov/pubmed/33738341
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2021.02.013
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados